Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Metabolomics Reagents Market by Type (Glycometabolism, Amino Acid Metabolism, Fatty Acid/Cholesterol Metabolism, Others), By Application (Diabetes, Obesity, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Metabolomics Reagents Market by Type (Glycometabolism, Amino Acid Metabolism, Fatty Acid/Cholesterol Metabolism, Others), By Application (Diabetes, Obesity, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 201029 3300 Chemical & Material 377 237 Pages 4.6 (37)
                                          

The global metabolomics reagents market is expected to grow at a CAGR of 12.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for personalized medicine and the growing number of research studies in metabolomics. The global metabolomics reagents market by type is segmented into glycometabolism, amino acid metabolism, fatty acid/cholesterol metabolism. The glycometabolism segment accounted for the largest share in 2018 and it is expected to continue its dominance throughout the forecast period due to its wide application in diabetes research. The amino acid metabolism segment accounted for a significant share in 2018 and it is expected to grow at a CAGR of 13% during the forecast period due to its wide application in obesity research. The fatty acid/cholesterol metabolism segment accounted for a small share in 2018 but it will grow at an impressive CAGR of 16% during the forecast period due to its wide application in cardiovascular diseases research. The global metabolomics reagents market by application includes diabetes, obesity, cardiovascular diseases and others (cancer). Diabetes was one of the leading applications accounting for over 40% share followed by obesity with over 30%. Cardiovascular diseases was one of other applications which accounted for less than 10%.

Some Of The Growth Factors Of This Market:

  1. The increasing prevalence of chronic diseases such as diabetes and obesity is driving the growth of the metabolomics reagents market.
  2. The increasing demand for personalized medicine is also driving the growth of the metabolomics reagents market.
  3. The growing number of research studies on metabolic disorders is expected to drive the growth of this market in future years.
  4. Increasing awareness about metabolic disorders among patients and healthcare providers will also drive this market in future years 5.Increasing funding for research on metabolic disorders will also fuel this market.

Industry Growth Insights published a new data on “Metabolomics Reagents Market”. The research report is titled “Metabolomics Reagents Market research by Types (Glycometabolism, Amino Acid Metabolism, Fatty Acid/Cholesterol Metabolism, Others), By Applications (Diabetes, Obesity, Others), By Players/Companies BioVision, Merck, Thermo Fisher Scientific, BD, Abbott, Kerafast, Beijing Strong Biotechnologies, Pointe Scientific, Luxcel Biosciences, Randox Laboratories Limited, Beijing Leadman Biochemistry, Shenzhen Bioeasy Biotechnology, Shenzhen Lvshiyuan Biotechnology, BioSino, NITTO BOSEKI”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Metabolomics Reagents Market Research Report

By Type

Glycometabolism, Amino Acid Metabolism, Fatty Acid/Cholesterol Metabolism, Others

By Application

Diabetes, Obesity, Others

By Companies

BioVision, Merck, Thermo Fisher Scientific, BD, Abbott, Kerafast, Beijing Strong Biotechnologies, Pointe Scientific, Luxcel Biosciences, Randox Laboratories Limited, Beijing Leadman Biochemistry, Shenzhen Bioeasy Biotechnology, Shenzhen Lvshiyuan Biotechnology, BioSino, NITTO BOSEKI

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

237

Number of Tables & Figures

166

Customization Available

Yes, the report can be customized as per your need.


Global Metabolomics Reagents Industry Outlook


Global Metabolomics Reagents Market Report Segments:

The global Metabolomics Reagents market is segmented on the basis of:

Types

Glycometabolism, Amino Acid Metabolism, Fatty Acid/Cholesterol Metabolism, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Diabetes, Obesity, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. BioVision
  2. Merck
  3. Thermo Fisher Scientific
  4. BD
  5. Abbott
  6. Kerafast
  7. Beijing Strong Biotechnologies
  8. Pointe Scientific
  9. Luxcel Biosciences
  10. Randox Laboratories Limited
  11. Beijing Leadman Biochemistry
  12. Shenzhen Bioeasy Biotechnology
  13. Shenzhen Lvshiyuan Biotechnology
  14. BioSino
  15. NITTO BOSEKI

Global Metabolomics Reagents Market Overview


Highlights of The Metabolomics Reagents Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Glycometabolism
    2. Amino Acid Metabolism
    3. Fatty Acid/Cholesterol Metabolism
    4. Others
  1. By Application:

    1. Diabetes
    2. Obesity
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Metabolomics Reagents Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Metabolomics Reagents Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Metabolomics reagents are used to identify and quantify the metabolites of a sample.

Some of the major companies in the metabolomics reagents market are BioVision, Merck, Thermo Fisher Scientific, BD, Abbott, Kerafast, Beijing Strong Biotechnologies, Pointe Scientific, Luxcel Biosciences, Randox Laboratories Limited, Beijing Leadman Biochemistry, Shenzhen Bioeasy Biotechnology, Shenzhen Lvshiyuan Biotechnology, BioSino, NITTO BOSEKI.

The metabolomics reagents market is expected to register a CAGR of 12.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Metabolomics Reagents Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Metabolomics Reagents Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Metabolomics Reagents Market - Supply Chain
   4.5. Global Metabolomics Reagents Market Forecast
      4.5.1. Metabolomics Reagents Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Metabolomics Reagents Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Metabolomics Reagents Market Absolute $ Opportunity

5. Global Metabolomics Reagents Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Metabolomics Reagents Market Size and Volume Forecast by Type
      5.3.1. Glycometabolism
      5.3.2. Amino Acid Metabolism
      5.3.3. Fatty Acid/Cholesterol Metabolism
      5.3.4. Others
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Metabolomics Reagents Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Metabolomics Reagents Market Size and Volume Forecast by Application
      6.3.1. Diabetes
      6.3.2. Obesity
      6.3.3. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Metabolomics Reagents Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Metabolomics Reagents Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Metabolomics Reagents Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Metabolomics Reagents Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Metabolomics Reagents Demand Share Forecast, 2019-2026

9. North America Metabolomics Reagents Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Metabolomics Reagents Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Metabolomics Reagents Market Size and Volume Forecast by Application
      9.4.1. Diabetes
      9.4.2. Obesity
      9.4.3. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Metabolomics Reagents Market Size and Volume Forecast by Type
      9.7.1. Glycometabolism
      9.7.2. Amino Acid Metabolism
      9.7.3. Fatty Acid/Cholesterol Metabolism
      9.7.4. Others
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Metabolomics Reagents Demand Share Forecast, 2019-2026

10. Latin America Metabolomics Reagents Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Metabolomics Reagents Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Metabolomics Reagents Market Size and Volume Forecast by Application
      10.4.1. Diabetes
      10.4.2. Obesity
      10.4.3. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Metabolomics Reagents Market Size and Volume Forecast by Type
      10.7.1. Glycometabolism
      10.7.2. Amino Acid Metabolism
      10.7.3. Fatty Acid/Cholesterol Metabolism
      10.7.4. Others
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Metabolomics Reagents Demand Share Forecast, 2019-2026

11. Europe Metabolomics Reagents Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Metabolomics Reagents Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Metabolomics Reagents Market Size and Volume Forecast by Application
      11.4.1. Diabetes
      11.4.2. Obesity
      11.4.3. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Metabolomics Reagents Market Size and Volume Forecast by Type
      11.7.1. Glycometabolism
      11.7.2. Amino Acid Metabolism
      11.7.3. Fatty Acid/Cholesterol Metabolism
      11.7.4. Others
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projctions by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Metabolomics Reagents Demand Share, 2019-2026

12. Asia Pacific Metabolomics Reagents Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Metabolomics Reagents Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Metabolomics Reagents Market Size and Volume Forecast by Application
      12.4.1. Diabetes
      12.4.2. Obesity
      12.4.3. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Metabolomics Reagents Market Size and Volume Forecast by Type
      12.7.1. Glycometabolism
      12.7.2. Amino Acid Metabolism
      12.7.3. Fatty Acid/Cholesterol Metabolism
      12.7.4. Others
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Metabolomics Reagents Demand Share, 2019-2026

13. Middle East & Africa Metabolomics Reagents Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Metabolomics Reagents Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Metabolomics Reagents Market Size and Volume Forecast by Application
      13.4.1. Diabetes
      13.4.2. Obesity
      13.4.3. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Metabolomics Reagents Market Size and Volume Forecast by Type
      13.7.1. Glycometabolism
      13.7.2. Amino Acid Metabolism
      13.7.3. Fatty Acid/Cholesterol Metabolism
      13.7.4. Others
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Metabolomics Reagents Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Metabolomics Reagents Market: Market Share Analysis
   14.2. Metabolomics Reagents Distributors and Customers
   14.3. Metabolomics Reagents Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. BioVision
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Merck
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Thermo Fisher Scientific
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. BD
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Abbott
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Kerafast
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Beijing Strong Biotechnologies
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Pointe Scientific
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Luxcel Biosciences
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Randox Laboratories Limited
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Beijing Leadman Biochemistry
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Shenzhen Bioeasy Biotechnology
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Shenzhen Lvshiyuan Biotechnology
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. BioSino
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. NITTO BOSEKI
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us